The first analysis of a weeklong series on recent reports related to aspects of the pharmaceutical industry covers IMS’ report giving projections on aspects of global drug use and spending through 2015 and SureScripts release of the most recent statistics on eprescribing use.
Our current Potpourri features Google’s dropping of its PHR, the AMA’s report on insurer claims paying, the role of health advocacy groups, employer’s intentions in regard to offering health coverage, drug approval in the US versus Europe and the use of a checklist to improve quality in the ICU.
A Rand report examines how self-insured employers might be affected by the PPACA, finding it unlikely that small employers will significantly shift to self-funding. The report also finds little reason to be concerned that self-funded plans are worse for employees.
A study finds that using home health care after a hospital admission for Medicare beneficiaries with certain chronic illnesses reduces Medicare Part A spending and readmissions compared to a beneficiary group that used other post-discharge services.
Deloitte issues the results of a global and a United States consumer survey on perceptions of health and health care system. Most Americans have a gloomy outlook, but so do the citizens of most of the surveyed countries.
Fireworks galore for the Fourth of July Potpourri, including dynamite excerpts on the effects of parent caregiving on caregivers’ financial status; health insurance exchanges; physician compensation; provider performance data gathering and use; hospital market concentration; use of HIT in nursing homes and teen use of health websites.
The second annual report by the Massachusetts AG on health care spending trends continues to find that provider market power is a major factor and that using a risk-based payment methodology does not reduce payment variation or lower medical spending or utilization.
Two articles describe in detail how Britain’s NICE operates in creating guidelines and conducting cost-effectiveness reviews. The process is highly transparent and professional, and while the institution has taken criticism for some of its decisions, its role is extremely important.
AHRQ issued yet another detailed, informative evidence review, this one on use of health information technology for medication management purposes. While many studies exist, the strength of the evidence for overall benefit is not as high as would be desirable.
PriceWaterhouseCooper discusses opportunities for health care business over the next decade, identifying new segments with growth, as well as challenges that must be overcome.